Literature DB >> 1710192

Expression of adhesion molecules during the formation and differentiation of the avian endocardial cushion tissue.

K L Crossin1, S Hoffman.   

Abstract

The expression of cytotactin, the cytotactin-binding (CTB) proteoglycan, and the neural cell adhesion molecule, N-CAM, was examined during the development of the avian endocardial cushion tissue (ECT). N-CAM was present in the cardiac mesoderm from its earliest time of development. At the time when endothelial cells converted to mesenchyme and began to migrate, they ceased their expression of N-CAM. Cytotactin and CTB proteoglycan were present in the cardiac jelly (into which the ECT cells migrate) in patterns that were correlated with cell migration. At early times of migration (stage 18), the region of the cardiac jelly near the endocardium contained cytotactin in the vicinity of the migrating cells. During later migration (stage 22), cytotactin remained associated with the leading zone of cell migration, but its expression began to decrease in areas where cells had accumulated. After ECT cell migration had ceased, cytotactin expression decreased, remaining high only in the peripheral portion of the aorticopulmonary septum and absent from its ridges. CTB proteoglycan was expressed during early migration at high levels in and adjacent to the myocardium. By stage 22, its distribution had become more uniform throughout the ECT regions and in the myocardium. The combined results of this study suggest that cytotactin, CTB proteoglycan, and N-CAM each play a distinct, critical role in pattern formation in the early heart.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1710192     DOI: 10.1016/0012-1606(91)90126-n

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  10 in total

Review 1.  Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling.

Authors:  Joyce A Schroeder; Leslie F Jackson; David C Lee; Todd D Camenisch
Journal:  J Mol Med (Berl)       Date:  2003-06-25       Impact factor: 4.599

2.  Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation.

Authors:  Melania E Mercado-Pimentel; Antony D Hubbard; Raymond B Runyan
Journal:  Dev Biol       Date:  2006-12-23       Impact factor: 3.582

3.  Morphogenetic alterations during endocardial cushion development in the trisomy 16 (Down syndrome) mouse.

Authors:  G G Hiltgen; R R Markwald; L L Litke
Journal:  Pediatr Cardiol       Date:  1996 Jan-Feb       Impact factor: 1.655

Review 4.  The extracellular matrix during heart development.

Authors:  C D Little; B J Rongish
Journal:  Experientia       Date:  1995-09-29

5.  Bone Marrow-Derived Tenascin-C Attenuates Cardiac Hypertrophy by Controlling Inflammation.

Authors:  Lei Song; Lai Wang; Fuqiang Li; Ada Yukht; Minghui Qin; Haley Ruther; Mingjie Yang; Aurelio Chaux; Prediman K Shah; Behrooz G Sharifi
Journal:  J Am Coll Cardiol       Date:  2017-09-26       Impact factor: 24.094

6.  A method for investigating spatiotemporal growth patterns at cell and tissue levels during C-looping in the embryonic chick heart.

Authors:  Nazanin Ebrahimi; Mahyar Osanlouy; Chris P Bradley; M Fabiana Kubke; Dane A Gerneke; Peter J Hunter
Journal:  iScience       Date:  2022-06-14

7.  The distribution and characterization of HNK-1 antigens in the developing avian heart.

Authors:  T M Luider; N Bravenboer; C Meijers; A W van der Kamp; D Tibboel; R E Poelmann
Journal:  Anat Embryol (Berl)       Date:  1993-09

Review 8.  Tenascin-C and mechanotransduction in the development and diseases of cardiovascular system.

Authors:  Kyoko Imanaka-Yoshida; Hiroki Aoki
Journal:  Front Physiol       Date:  2014-07-29       Impact factor: 4.566

9.  NCAM polypeptides in heart development: association with Z discs of forms that contain the muscle-specific domain.

Authors:  M K Byeon; Y Sugi; R R Markwald; S Hoffman
Journal:  J Cell Biol       Date:  1995-01       Impact factor: 10.539

10.  Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular development.

Authors:  Srinivasan Dinesh Kumar; S Thameem Dheen; Samuel Sam Wah Tay
Journal:  Cardiovasc Diabetol       Date:  2007-10-30       Impact factor: 9.951

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.